Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Colorcon
Daiichi Sankyo
QuintilesIMS
Cantor Fitzgerald
Dow
AstraZeneca
Boehringer Ingelheim

Generated: November 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020748

« Back to Dashboard

NDA 020748 describes DIFFERIN, which is a drug marketed by Galderma Labs Lp and is included in five NDAs. It is available from seven suppliers. There are nine patents protecting this drug and one Paragraph IV challenge. Additional details are available on the DIFFERIN profile page.

The generic ingredient in DIFFERIN is adapalene. There are twelve drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the adapalene profile page.
Summary for 020748
Tradename:DIFFERIN
Applicant:Galderma Labs Lp
Ingredient:adapalene
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020748
Ingredient-typeRetinoids
Medical Subject Heading (MeSH) Categories for 020748
Suppliers and Packaging for NDA: 020748
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIFFERIN adapalene CREAM;TOPICAL 020748 NDA GALDERMA LABORATORIES, L.P 0299-5915 0299-5915-45 1 TUBE in 1 CARTON (0299-5915-45) > 45 g in 1 TUBE
DIFFERIN adapalene CREAM;TOPICAL 020748 NDA Perrigo New York Inc 45802-453 45802-453-84 1 TUBE in 1 CARTON (45802-453-84) > 45 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.1%
Approval Date:May 26, 2000TE:ABRLD:Yes

Expired US Patents for NDA 020748

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Galderma Labs Lp DIFFERIN adapalene CREAM;TOPICAL 020748-001 May 26, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Galderma Labs Lp DIFFERIN adapalene CREAM;TOPICAL 020748-001 May 26, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Chubb
Cipla
Covington
Federal Trade Commission
Fuji
Colorcon
Cerilliant
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.